title: [RATIONAL ASPECTS OF BACTERIOPHAGES USE].
abstract: OBJECTIVE
  Analysis of existing aspects of bacteriophage use and study features of their lytic activity by using various techniques.
  
  
  METHODS
  Effect of monophages and associated bacteriophages (staphylococci, piopolyvalent and piocombined, intestiphage, pneumonia klebsiella and polyvalent klebsiella produced by "Microgen") was studied with 380 strains of Staphylococcus aureus and 279 cultures of Klebsiella pneumoniae in liquid and solid nutrient media. From patients with intestinal disorder, sensitivity was analyzed to 184 strains of Salmonella genus bacteria 18 serological variants to salmonella bacteriophages, 137 strains of Escherichia coli (lactose-negative, hemolytic), as well as some members of OKA groups (21 serovars) to coli-proteic and piopolyvalent bacteriophages. Lytic ability of the piobacteriophage against Klebsiella and Proteus genus bacteria was determined.
  
  
  RESULTS
  Staphylococcus aureus was sensitive to staphylococcus bacteriophage in 71.6% of cases and to piobacteriophage--in 86.15% of cases. A 100% lytic ability of salmonella bacteriophage against Salmonella spp. was established. Sensitivity of E. coli of various serogroups to coli-proteic and piobacteriophage was 66 - 100%. Klebsiella, Proteus genus bacteria were sensitive to piobacteriophage in only 35% and 43.15% of cases, respectively.
  
  
  CONCLUSIONS
  A more rational use of bacteriophages is necessary: development of a technique, evaluation of sensitivity of bacteria to bacteriophage, introduction of corrections into their production (expansion of bacteriophage spectra, determination and indication of their concentration in accompanying documents).
authors.forename: A A
authors.initials: AA
authors.lastname: Vakarina
authors.forename: L V
authors.initials: LV
authors.lastname: Kataeva
authors.forename: N F
authors.initials: NF
authors.lastname: Karpukhina
mesh_terms: D001435:Bacteriophages / Q000235:genetics / Q000378:metabolism / Q000472:pathogenicity*; D006801:Humans; D007711:Klebsiella pneumoniae / Q000254:growth & development / Q000821:virology*; D013045:Species Specificity; D013211:Staphylococcus aureus / Q000254:growth & development / Q000821:virology*